Compare Bio Protocol (BIO) vs Venice Token (VVV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Venice Token — how do they compare? Bio Protocol trades at Rp517.15 (market cap Rp1,15T, Rp264,79M 24h volume), while Venice Token trades at Rp195,467 (market cap Rp9,17T, Rp365,37M 24h volume). The key difference: Venice Token is far larger — about 8× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Venice Token's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Venice Token for 5 Days on average.
| BIO | VVV | |
|---|---|---|
Market Cap | Rp1,15T | Rp9,17T |
Volume (24h) | Rp264,79M | Rp365,37M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 47,3M VVV |
Typical Hold Time | 16 Days | 5 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
No Aura AI signal available yet.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Venice Token
Venice.ai is a private and censorship-resistant generative AI platform that facilitates text conversations, image and code generation, and AI character interactions. It is built on open-source models and powered by decentralized infrastructure. Founded in May 2024 and led by Erik Voorhees and Teana Baker-Taylor.
Read more on VVV →
